CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirsh, V. A.
Right arrow Articles by Hayes, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirsh, V. A.
Right arrow Articles by Hayes, R. B.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 92-98, January 2006
© 2006 American Association for Cancer Research

A Prospective Study of Lycopene and Tomato Product Intake and Risk of Prostate Cancer

Victoria A. Kirsh1,2, Susan T. Mayne2, Ulrike Peters1, Nilanjan Chatterjee1, Michael F. Leitzmann1, L. Beth Dixon3, Donald A. Urban4, E. David Crawford5 and Richard B. Hayes1

1 Division of Cancer Epidemiology and Genetics, Intramural Research Program, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 2 Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; 3 Department of Nutrition, Food Studies, and Public Health, New York University, New York, New York; 4 Department of Surgery, Division of Urology, University of Alabama at Birmingham, Birmingham, Alabama; and 5 Division of Urologic Oncology, University of Colorado, Aurora, Colorado

Requests for reprints: Richard B. Hayes, EPN 8114, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892. Phone: 301-435-3973; Fax: 301-402-1819. E-mail: hayesr{at}mail.nih.gov

Background: Dietary lycopene and tomato products may reduce risk of prostate cancer; however, uncertainty remains about this possible association.

Methods: We evaluated the association between intake of lycopene and specific tomato products and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, a multicenter study designed to investigate cancer early detection methods and etiologic determinants. Participants completed both a general risk factor and a 137-item food frequency questionnaire at baseline. A total of 1,338 cases of prostate cancer were identified among 29,361 men during an average of 4.2 years of follow-up.

Results: Lycopene intake was not associated with prostate cancer risk. Reduced risks were also not found for total tomato servings or for most tomato-based foods. Statistically nonsignificant inverse associations were noted for pizza [all prostate cancer: relative risk (RR), 0.83; 95% confidence interval (95% CI), 0.67-1.03 for ≥1 serving/wk versus < 0.5 serving/mo; Ptrend = 0.06 and advanced prostate cancer: RR, 0.79; 95% CI, 0.56-1.10; Ptrend = 0.12] and spaghetti/tomato sauce consumption (advanced prostate cancer: RR = 0.81, 95% CI, 0.57-1.16 for ≥2 servings/wk versus < 1 serving/mo; Ptrend = 0.31). Among men with a family history of prostate cancer, risks were decreased in relation to increased consumption of lycopene (Ptrend = 0.04) and specific tomato-based foods commonly eaten with fat (spaghetti, Ptrend = 0.12; pizza, Ptrend = 0.15; lasagna, Ptrend = 0.02).

Conclusions: This large study does not support the hypothesis that greater lycopene/tomato product consumption protects from prostate cancer. Evidence for protective associations in subjects with a family history of prostate cancer requires further corroboration. (Cancer Epidemiol Biomarkers Prev 2006;15(1):92–8)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. N. Syed, N. Khan, F. Afaq, and H. Mukhtar
Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2193 - 2203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. J Key, P. N Appleby, N. E Allen, R. C Travis, A. W Roddam, M. Jenab, L. Egevad, A. Tjonneland, N. F Johnsen, K. Overvad, et al.
Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 672 - 681.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. A. Kirsh, U. Peters, S. T. Mayne, A. F. Subar, N. Chatterjee, C. C. Johnson, and R. B. Hayes
Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer
J Natl Cancer Inst, August 1, 2007; 99(15): 1200 - 1209.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Giovannucci
Does Prostate-Specific Antigen Screening Influence the Results of Studies of Tomatoes, Lycopene, and Prostate Cancer Risk?
J Natl Cancer Inst, July 18, 2007; 99(14): 1060 - 1062.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
U. Peters, M. F. Leitzmann, N. Chatterjee, Y. Wang, D. Albanes, E. P. Gelmann, M. D. Friesen, E. Riboli, and R. B. Hayes
Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 962 - 968.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. P. Kumar, S. Bhaskaran, M. Ganapathy, K. Crosby, M. D. Davis, P. Kochunov, J. Schoolfield, I-T. Yeh, D. A. Troyer, and R. Ghosh
Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract
Clin. Cancer Res., May 1, 2007; 13(9): 2784 - 2794.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.